Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study
- 18 February 2025
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 32 (3) , 520-528
Abstract
Background Early prediction and management are crucial for treating breast cancer-related lymphedema (BCRL), yet the risk factors remain poorly understood. This study aims to explore the relationship between postoperative changes in serum cholesterol levels and the development of lymphedema. Methods This retrospective study analyzed breast cancer patients who underwent surgery between March 2014 and March 2019. We assessed the development of lymphedema and changes in high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and total cholesterol (TC) levels. Preoperative values were compared with those measured within 6 months post-surgery, and logistic regression models were used for statistical analysis. Results Among the 906 patients studied, 87 (9.6%) developed lymphedema, with a median onset of 15 months. An increase in serum HDL levels relative to baseline was associated with a reduced risk of lymphedema (odds ratio [OR] 0.94 per unit increase, 95% confidence interval [CI]: 0.92–0.95), even after adjusting for established factors such as body mass index, type of axillary surgery, number of lymph nodes removed, regional radiotherapy, and chemotherapy. In contrast, elevated serum TG levels were linked to a higher risk of lymphedema (OR 1.003 per unit increase, 95% CI: 1.001–1.006). No significant associations were found with changes in LDL or TC levels (p > 0.05). Conclusion Postoperative changes in HDL and TG levels are significantly associated with the risk of developing lymphedema, suggesting their potential role as early indicators. These results have important clinical implications for guiding follow-up care and early intervention strategies, although further validation is needed.Keywords
This publication has 38 references indexed in Scilit:
- Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05)Breast Cancer Research and Treatment, 2022
- Development and Validation of a Risk Model for Breast Cancer–Related LymphedemaJAMA Network Open, 2020
- Complicated breast cancer–related lymphedema: evaluating health care resource utilization and associated costs of managementThe American Journal of Surgery, 2016
- Suitable therapy options for sub-clinical and early-stage lymphoedema patientsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2014
- Comparison of lymphoscintigraphy and indocyanine green lymphography for the diagnosis of extremity lymphoedemaJournal of Plastic, Reconstructive & Aesthetic Surgery, 2013
- Upper‐body morbidity after breast cancerCancer, 2012
- Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatmentPsycho-Oncology, 2009
- Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular BenefitCardiovascular Drugs and Therapy, 2008
- Preoperative assessment enables the early diagnosis and successful treatment of lymphedemaCancer, 2008
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJAMA, 2007